Synthetic cannabis
Tidsskr Nor Laegeforen. 2012 Oct 30;132(20):2289.
doi: 10.4045/tidsskr.12.0661.
[Article in
English,
Norwegian]
Affiliation
- 1 Department of Clinical Pharmacology, St. Olav University Hospital, Norway. andreas.westin@legemidler.no
No abstract available
MeSH terms
-
Cannabinoids / adverse effects
-
Cannabinoids / analysis*
-
Cannabinoids / pharmacology
-
Cannabis / adverse effects*
-
Designer Drugs / adverse effects
-
Designer Drugs / analysis*
-
Designer Drugs / pharmacology
-
Gas Chromatography-Mass Spectrometry
-
Humans
-
Illicit Drugs / adverse effects
-
Illicit Drugs / analysis
-
Illicit Drugs / pharmacology
-
Indoles / adverse effects
-
Indoles / analysis*
-
Indoles / pharmacology
-
Marijuana Smoking / adverse effects
-
Naphthalenes / adverse effects
-
Naphthalenes / analysis*
-
Naphthalenes / pharmacology
Substances
-
Cannabinoids
-
Designer Drugs
-
Illicit Drugs
-
Indoles
-
Naphthalenes
-
1-pentyl-3-(1-naphthoyl)indole